Attached files
| file | filename |
|---|---|
| S-1 - S-1 - Aralez Pharmaceuticals Inc. | a2226999zs-1.htm |
| EX-10.2 - EX-10.2 - Aralez Pharmaceuticals Inc. | a2226999zex-10_2.htm |
| EX-10.1 - EX-10.1 - Aralez Pharmaceuticals Inc. | a2226999zex-10_1.htm |
| EX-23.4 - EX-23.4 - Aralez Pharmaceuticals Inc. | a2226999zex-23_4.htm |
| EX-10.3 - EX-10.3 - Aralez Pharmaceuticals Inc. | a2226999zex-10_3.htm |
| EX-23.2 - EX-23.2 - Aralez Pharmaceuticals Inc. | a2226999zex-23_2.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Auditors
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated February 27, 2015 with respect to the financial statements of Tribute Pharmaceuticals Canada Inc. included in this Registration Statement (Form S-1) and related Prospectus of Aralez Pharmaceuticals Inc. for the registration of the resale of 7,200,000 shares of Aralez Pharmaceuticals Inc. common shares.
McGovern, Hurley, Cunningham, LLP
Chartered Accountants
Licensed Public Accountants
December 31,
2015
Toronto, Canada
Consent of Independent Auditors